Options to enhance the efficacy of cognitive-behavior therapy of insomnia

Zavalko I.M.

doi:https://doi.org/10.17116/jnevro202112140236

Close metadata

Recommended articles:

Consensus of the Russian Society of Sleep Medicine on the real-world application of cognitive-behavioral therapy of insomnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):38-45

The use of zolpidem in the treatment of acute and chronic insomnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):52-56

Sleep disturbance in patients with chronic nonspecific neck pain before and after radiofrequency denervation. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):87-91

Cerebrovascular disease in clinical practice. Resolution of the Expert Council of the Russian Scientific Medical Society of Therapists. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):105-111

Abstract:

Cognitive-behavior therapy of insomnia (CBT-I) is first-line treatment for insomnia, but it produces a clinical significant result only in 60—80% of patients. Addition reason of reduction of CBT-I efficacy is a relatively low adherence: the attrition rate is 10—39%. The authors discuss options to enhance efficacy of the therapy by usage of complex approach, individualized choice of technics, motivating a patient and his relatives, and combination of CBT-I with hypnotics.

Keywords:

cognitive-behavior therapy of insomnia

treatment adherence

hypnotics

Authors:

Zavalko I.M.

State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Received:

02.03.2021

Accepted:

18.03.2021

Close metadata

References:

Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700. https://doi.org/10.1111/jsr.12594
Qaseem A, Kansagara D, Forciea MA, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. https://doi.org/10.7326/M15-2175
Smith MT, Perlis ML, Park A, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159(1):5-11. https://doi.org/10.1176/appi.ajp.159.1.5
van Straten A, van der Zweerde T, Kleiboer A, et al. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018;38:3-16. https://doi.org/10.1016/j.smrv.2017.02.001
Harvey AG, Bélanger L, Talbot L, et al. Comparative efficacy of behavior therapy, cognitive therapy, and cognitive behavior therapy for chronic insomnia: a randomized controlled trial. J Consult Clin Psychol. 2014;82(4):670-683. https://doi.org/10.1037/a0036606
Morin CM, Bootzin RR, Buysse DJ, et al. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998—2004). Sleep. 2006;29(11):1398-1414. https://doi.org/10.1037/a0036606
Ong JC, Kuo TF, Manber R. Who is at risk for dropout from group cognitive-behavior therapy for insomnia? J Psychosom Res. 2008;64(4):419-425. https://doi.org/10.1016/j.jpsychores.2007.10.009
Perlis M, Aloia M, Kuhn B, eds. Behavioral Treatments for Sleep Disorders: A Comprehensive Primer of Behavioral Sleep Medicine Interventions. 1st ed. Academic Press; 2011;404.
Chung KF, Lee CT, Yeung WF, et al. Sleep hygiene education as a treatment of insomnia: a systematic review and meta-analysis. Fam Pract. 2018;35(4):365-375. https://doi.org/10.1093/fampra/cmx122
Harvey L, Inglis SJ, Espie CA. Insomniacs’ reported use of CBT components and relationship to longterm clinical outcome. Behav Res Ther. 2002;40(1):75-83. https://doi.org/10.1016/s0005-7967(01)00004-3
Edinger JD, Wohlgemuth WK, Radtke RA, et al. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA. 2001;285(14):1856-1864. https://doi.org/10.1001/jama.285.14.1856
Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med. 2004;164(17):1888-1896. https://doi.org/10.1001/archinte.164.17.1888
Morin CM, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999;281(11):991-999. https://doi.org/10.1001/jama.281.11.991
Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA. 2006;295(24):2851-2858. https://doi.org/10.1001/jama.295.24.2851
Perlis M, Aloia M, Millikan A, et al. Behavioral treatment of insomnia: a clinical case series study J Behav Med. 2000;23(2):149-161. https://doi.org/10.1023/a:1005413117932
Vincent N, Lewycky S, Finnegan H. Barriers to engagement in sleep restriction and stimulus control in chronic insomnia. J Consult Clin Psychol. 2008;76(5):820-828. https://doi.org/10.1037/0022-006X.76.5.820
Manber R, Bernert RA, Suh S, et al. CBT for insomnia in patients with high and low depressive symptom severity: adherence and clinical outcomes. J Clin Sleep Med. 2011;7(6):645-652. https://doi.org/10.5664/jcsm.1472
McChargue DE, Sankaranarayanan J, Visovsky CG, et al. Predictors of adherence to a behavioral therapy sleep intervention during breast cancer chemotherapy. Support Care Cancer. 2012;20(2):245-252. https://doi.org/10.1007/s00520-010-1060-1
Vincent NK, Hameed H. Relation between adherence and outcome in the group treatment of insomnia. Behav Sleep Med. 2003;1(3):125-139. https://doi.org/10.1207/S15402010BSM0103_1
Hebert EA, Vincent N, Lewycky S, Walsh K. Attrition and adherence in the online treatment of chronic insomnia. Behav Sleep Med. 2010;8(3):141-150. https://doi.org/10.1080/15402002.2010.487457
Constantino MJ, Manber R, Ong J, et al. Patient expectations and therapeutic alliance as predictors of outcome in group cognitive-behavioral therapy for insomnia. Behav Sleep Med. 2007;5(3):210-228. https://doi.org/10.1080/15402000701263932
Vincent N, Lionberg C. Treatment preference and patient satisfaction in chronic insomnia. Sleep. 2001;24(4):411-417. https://doi.org/10.1093/sleep/24.4.411
Tremblay V, Savard J, Ivers H. Predictors of the effect of cognitive behavioral therapy for chronic insomnia comorbid with breast cancer. J Consult Clin Psychol. 2009;77(4):742-750. https://doi.org/10.1037/a0015492
Matthews EE, Schmiege SJ, Cook PF, et al. Adherence to cognitive behavioral therapy for insomnia (CBTI) among women following primary breast cancer treatment: a pilot study. Behav Sleep Med. 2012;10(3):217-229. https://doi.org/10.1080/15402002.2012.666220
Kyle SD, Morgan K, Spiegelhalder K, Espie CA. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med. 2011;12(8):735-747. https://doi.org/10.1016/j.sleep.2011.03.016
Kyle SD, Miller CB, Rogers Z, et al. Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder. Sleep. 2014;37(2):229-237. https://doi.org/10.5665/sleep.3386
Smith MT, Perlis ML. Who is a candidate for cognitive-behavioral therapy for insomnia? Health Psychol. 2006;25(1):15-19. https://doi.org/10.1037/0278-6133.25.1.15
Cheung J, Ji X, Morin C. Cognitive Behavioral Therapies for Insomnia and Hypnotic Medications: Considerations and Controversies. Sleep Med Clin. 2019;14(2):253-265. https://doi.org/10.1016/j.jsmc.2019.01.006
Wu R, Bao J, Zhang C, et al. Comparison of sleep condition and sleep-related psychological activity after cognitive-behavior and pharmacological therapy for chronic insomnia. Psychother Psychosom. 2006;75(4):220-228. https://doi.org/10.1159/000092892
Morin CM, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009;301(19):2005-2015. https://doi.org/10.1001/jama.2009.682
Morin CM, Beaulieu-Bonneau S, Ivers H, et al. Speed and trajectory of changes of insomnia symptoms during acute treatment with cognitive-behavioral therapy, singly and combined with medication. Sleep Med. 2014;15(6):701-707. https://doi.org/10.1016/j.sleep.2014.02.004
Hauri PJ. Can we mix behavioral therapy with hypnotics when treating insomniacs? Sleep. 1997;20(12):1111-1118. https://doi.org/10.1093/sleep/20.12.1111
Beaulieu-Bonneau S, Ivers H, Guay B, Morin CM. Long-Term Maintenance of Therapeutic Gains Associated with Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined with Zolpidem. Sleep. 2017;40(3):zsx002. https://doi.org/10.1093/sleep/zsx002
Zavesicka L, Brunovsky M, Horacek J, et al. Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients. Neuro Endocrinol Lett. 2008;29(6):895-901.
Wein AM. Otchet ob issledovanii Donormila u bolnih insomniey. M. 1997. (In Russ.).
Sjöqvist F, Lasagna L. The hypnotic efficacy of doxylamine. Clin Pharmacol Ther. 1967;8(1):48-54. https://doi.org/10.1002/cpt196781part148
Hausser Hauw C, Fleury B, Scheck F, et al. Effect on sleep architecture and residual effect of a dose of 15 mg of Doxylamine in healthy volunteers. Sep Hop Paris. 1995;71(23-24):742-750.
Stahl SM. Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr. 2008;13(12):1027-1038. https://doi.org/10.1017/s1092852900017089